TRx has initially focussed on establishing and progressing its technology in a series of focussed co-development product programmes:
- Molecules and diseases have been selected with strong relevance to TRx platform benefits
- Co-development programmes have moved through technology and value inflection points and rapidly on to clinic
Our co-development phase is well established, creating both value and a secure technology evidence base.